Loading…
Based on limited metadata, IDT Australia Ltd. received an FDA Warning Letter on May 23, 2018, regarding products classified outside the traditional device/drug categories. Without access to the full letter text or specified subject matter, the specific regulatory violations cannot be detailed; however, the warning indicates significant compliance concerns that prompted formal FDA action. The issuing office information is unavailable, limiting clarity on which FDA division addressed this matter. Additional documentation would be needed to identify the precise nature of the violations and required corrective actions.